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ABSTRACT
Background and Objectives: Erectile function after
prostate surgery is an important criterion for patients
when they are choosing a treatment modality for prostate
cancer. Improved visualization, dexterity, and precision
afforded by the da Vinci robot allow a precise dissection
of the neurovascular bundles. We objectively assessed
erectile function after robot-assisted extraperitoneal pros-
tatectomy by using the SHIM (IIEF-5) validated question-
naire.
Methods: Between July 2003 and September 2004, 150
consecutive men underwent da Vinci robot-assisted extra-
peritoneal radical prostatectomy for clinically localized
prostate cancer. The IIEF-5 questionnaire was used to
assess postoperative potency in 67 patients who were at
least 6 months postsurgery. Erectile function was classi-
fied as impotent (11), moderate dysfunction (11 to 15),
mild dysfunction (16 to 21), and potent (22 to 25). All pa-
tients used oral pharmacological assistance postprocedure.
Results: Sixty-seven patients were available to complete
the IIEF-5 questionnaire 6 months to 1 year postprostate-
ctomy. Twelve patients were excluded from the study
who abstained from all sexual activity after surgery for
emotional or social reasons. Of the 55 patients evaluated,
22 (40%) were impotent, 3 (5.5%) had moderate erectile
dysfunction (ED), 12 (21.8%) had mild ED, and 18 (32.7%)
were fully potent. The table compares IIEF-5 scores with
nerve-sparing status. Of patients who had bilateral nerve
sparing, 28/45 (62.2%) had mild or no ED within 6 to 12
months postsurgery, and all expressed satisfaction with
their current sexual function or rate of improvement after
robotic prostatectomy.
Conclusion: Robot-assisted extraperitoneal prostatec-
tomy provides comparable outcomes to those of open
surgery with regards to erectile function. Assessment of
the ultimate maximal erectile function will require contin-
ued analysis, as this is likely to further improve beyond 6
to 12 months.
Key Words: Robotics, Prostatectomy, Sexual dysfunction,
Postoperative complications.
INTRODUCTION
During the last 5 years, advances in laparoscopic equip-
ment and technique, including the addition of the da Vinci
surgical system (Intuitive Surgical, Mountain View, Cali-
fornia), have resulted in significant progress in the devel-
opment of minimally invasive surgery for localized pros-
tate cancer. The combination of less postoperative
morbidity, improved cosmesis, shorter convalescence,
and the possibility of comparable outcomes has lured
patient demand away from the conventional open retro-
pubic prostatectomy technique. Robot-assisted prostatec-
tomy has been widely popularized with over 1000 cases
already reported in the literature by a single surgeon.1 At
our institution, we developed a total extraperitoneal lapa-
roscopic and robotic approach and found this procedure
to be technically feasible and reproducible.2–4 Robot-as-
sisted prostatectomy has been performed at multiple cen-
ters in both the United States and Europe, with early
oncological and functional results still being reported.5–9
Objective data using validated questionnaires on postro-
bot-assisted nerve-sparing radical prostatectomy are
sparse. We objectively assessed erectile function after ro-
bot-assisted extraperitoneal prostatectomy by using the
5-item version of the International Index of Erectile Func-
tion (IIEF-5),10 also known as the Sexual Health Inventory
for Men (SHIM), validated questionnaire.
METHODS
Patients and Data
Analysis of our first 150 patients undergoing extraperito-
neal robotic prostatectomy by the same surgeon (JVJ) was
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SCIENTIFIC PAPERperformed. We prospectively collected baseline demo-
graphic data, such as race, body mass index, serum pros-
tate-specific antigen (PSA), prostate volume, Gleason
grade/sum, clinical stage, and associated co-morbidities.
Perioperative, intraoperative, and postoperative data
along with early functional and short-term oncological
results were also prospectively enrolled, recorded, and
analyzed. The indications for laparoscopic prostatectomy
were identical to those of the conventional open radical
retropubic prostatectomy. A nerve-sparing procedure was
applied to all patients where oncological control was not
jeopardized, regardless of preoperative sexual activity.
Bilateral and unilateral nerve-sparing procedures were
performed in 93 and 24 patients, respectively. Table 1
reviews the clinical features of the first 150 patients un-
dergoing extraperitoneal robot-assisted nerve-sparing rad-
ical prostatectomy at our institution.
Procedure
Our method for development of extraperitoneal pneumo-
peritoneum and development of the space of Retzius is
based on our preliminary experience with laparoscopic
radical prostatectomy and has been described else-
wherere.2,4 Briefly, the procedure is performed in an an-
tegrade fashion with initial transection of the bladder neck
and exposure of the seminal vesicles.
Anatomical Nerve-sparing Technique and
Considerations
The nerve-sparing operation commences after the seminal
vesicles are freed, and the lateral prostatic pedicles are
dissected with the reflection of the lateral pelvic fascia off
the prostate. The vessels entering the prostate base are
selectively coagulated by using bipolar forceps before
their transection with da Vinci articulating scissors.
Functional Results
The SHIM validated questionnaire11 was used to assess
potency status at the 6-month and yearly follow-up visit or
during a separate phone interview by a third party.10 All
patients receive a prescription for oral pharmacological
assistance postprocedure and are instructed on its use.
The degree of erectile function was classified into 4
grades: 11impotent; 11 to 15moderate erectile dys-
function (ED); 16 to 21mild ED; 22 to 25potent. The
patients’ scores were tabulated and entered into an Excel
database.
RESULTS
Functional Outcome
A nerve-sparing procedure was performed in 117 of the
first 150 patients, 24 unilateral and 93 bilateral. The addi-
tional 33 patients had preplanned nonnerve-sparing ro-
botic-assisted prostatectomies to avoid compromising
cancer control. The high-risk features used to exclude
patients from a nerve-sparing approach were Gleason
sum/grade, PSA, number of positive biopsies, and clinical
stage. This was discussed in detail with the patients before
surgery. The IIEF-5 questionnaire was used to assess post-
operative potency in 67 patients who were at least 6
months postsurgery. Erectile function was classified as
impotent (11); moderate dysfunction (11 to 15); mild
dysfunction (16 to 21); and potent (22 to 25). All patients
used oral pharmacological assistance postprocedure.
Twelve patients were excluded who abstained from all
sexual activity after surgery for emotional or social rea-
sons. From the remaining 55 patients evaluated, 4 had
nonnerve-sparing, 6 had unilateral nerve-sparing, and 45
had bilateral nerve-sparing. Of the 55 patients, 22 (40%)
were impotent, 3 (5.5%) had moderate ED, 12 (21.8%) had
mild ED, and 18 (32.7%) were fully potent. Table 2 com-
pares IIEF-5 scores with nerve-sparing status. Of patients
who had bilateral nerve sparing, 28/45 (62.2%) had mild
or no ED within 6 to 12 months postsurgery, and all
Table 1.
Clinical Parameters and Intraoperative Data of 150 Patients
Undergoing Extraperitoneal Robot-assisted Nerve-sparing
Radical Prostatectomy at Our Institution
Parameter Mean (Range)
Age (y) 60 (46–76)
Pre-op Prostate-Specific Antigen 6.6 (0.6–26)
Clinical Stage
T1c 126
T2a 22
T2b 2
Gleason Score 6 (4–8)
Operative Time (min including docking) 223 (163–486)
Blood Loss (mL) 196
Nerve Sparing 117
Unilateral 24
Bilateral 93
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JSLS (2007)11:443–448 444expressed satisfaction with their current sexual function or
rate of improvement after robotic prostatectomy (Table
2). When stratified by age, men under 60 more frequently
had an erection sufficient for sexual intercourse than those
who were older (mean IIEF-5 scores, 17.6 versus 10.8;
P0.05). At 6-month follow-up, 20/30 patients (67%) who
were 60 years of age reported mild ED or were fully
potent, compared with 10/25 (40%) in patients older than
60. Ability to reach an orgasm was asked as a separate
question after the set of validated questions. Independent
of whether the patients were potent or had erectile dys-
function, greater than 80% of the men remarked that they
were able to attain an orgasm or did not have a change in
their ability to attain an orgasm.
DISCUSSION
The introduction of the anatomical nerve-sparing prosta-
tectomy resulted in improved sexual function without
compromising cancer control.11–13 In the PSA era, as pa-
tients are being increasingly diagnosed with localized
prostate cancer, a main focus of treatment has become
prevention of significant nonlife-threatening morbidity
(such as incontinence and erectile dysfunction) while
maintaining cancer control. The multiple advantages af-
forded by the robot (increased precision and dexterity
with wristed instrumentation, ergonomic manipulation,
and 3-dimensional visualization with 10x magnification)
have encouraged both laparoscopically naı ¨ve and trained
surgeons to embrace this technique.5 Current reports have
already shown superior return of urinary control when
compared with that of open surgery.
1,7–9,14 In addition,
early series have demonstrated comparable early tumor
control and oncological outcomes.
1,6–9,14 As opposed to
tumor control and incontinence, where there are objective
tests that can accurately determine functional and onco-
logical outcomes, preservation of sexual function remains
a difficult outcome to assess and quantify. The process of
achieving a successful erection for intercourse is depen-
dent on multiple patient parameters including age, co-
morbid medical conditions like diabetes and peripheral
vascular disease, psychological, behavioral, and social
factors. In addition, varying surgical technique and oper-
ative modality as well as differences in surgeons’ patient
selection has further compromised our understanding of
postoperative potency status. Finally, the different defini-
tions of postoperative potency and erectile dysfunction
used as well as the multiple validated questionnaires in
existence have made it even harder to assess. Therefore,
more reports using objective data are needed to better
treat patients postoperatively.
There has been a wide range of postnerve-sparing pros-
tatectomy potency rates in the world literature. Walsh
reported on 64 patients who underwent conventional
open prostatectomy with bilateral neurovascular nerve
preservation and found 73% of the patients were potent
and sexually active.15,16 In a series by Catalona et al,17 68%
recovery of erections after bilateral, and 41% after unilat-
eral nerve-sparing surgery was reported. When stratified
by age, they found a 75% return of erection in patients
60 who had bilateral nerve-sparing surgery.17 Gralnek et
al18 demonstrated a 39% potency rate in 46 men after
unilateral nerve preservation, and in a more recent series,
Rabbani et al19 reported on 314 men undergoing open
radical prostatectomy and found unilateral nerve preser-
vation to be associated with a 25% rate of erectile function,
while bilateral nerve sparing was associated with a 47%
rate in patients older than 65 years of age and 76% in
patients who were younger. Others have reported a large
range of potency rates varying between 11% to 86% (Ta-
ble 3).20,21
A large series from Johns Hopkins University demon-
strated age to be a predictor of recovery of potency.22
They showed that in patients 50 years of age, regardless
of the extent of nerve sparing, there was no difference in
potency rates. In patients between 50 and 60 years of age,
not only was the overall potency rate decreased, but
recovery of erectile function was strongly dependent on
whether one or both neurovascular bundles were pre-
served. Reports by Catalona et al17 and Rabbani et al19 also
demonstrated that age and extent of nerve preservation
were strong predictors of the return of erectile function.
Reports on erectile function after laparoscopic and robotic
nerve-sparing radical prostatectomy have been scant.
Moreover, the initial data were subjective without the use
of validated questionnaires. Turk et al23 reported on 125
patients who underwent laparoscopic prostatectomy. Of
Table 2.
Erectile Function by Nerve-Sparing Status
IIEF-5
Score
Class of
Erectile
Dysfunction
Nonnerve
Sparing
Unilateral
Nerve
Sparing
Bilateral
Nerve
Sparing
11 Impotent 4 3 15
11–15 Moderate – 1 2
16–21 Mild – – 12
22–25 Potent – 2 16
Total Patients – 4 6 45
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tercourse and 8 needing pharmacological assistance.
Rassweiler et al24 reported on 100 patients undergoing
laparoscopic radical prostatectomy, whereby 10 patients
underwent unilateral nerve-sparing surgery with only 4 of
these men having intercourse with the aid of pharmaco-
therapy. Six of 10 patients undergoing laparoscopic bilat-
eral nerve-sparing prostatectomy had successful inter-
course in a series by Bollens et al,25 a n d9o f2 0
(preoperative potent patients) undergoing laparoscopic
bilateral nerve-sparing prostatectomy had successful inter-
course in Guillonneau and Vallancien’s early series.26 Sub-
sequently, both teams reported potency rates of 65% and
66%, respectively, in their larger series.27,28 Using sexual
function questionnaires, Katz et al29 reported on 143 pa-
tients undergoing laparoscopic nerve-sparing radical
prostatectomy. Fifty-eight percent of patients who had
erections preoperatively maintained their erections after
surgery.29
There have been even fewer reports of potency outcome
after robotic-assisted nerve-sparing surgery compared
with laparoscopic and open surgery. Menon et al reported
82% of preoperatively potent patients younger than 60
having a return of some sexual activity using the ex-
Table 3.
Reported Potency Rates and Method of Prostatectomy
Series Type of Prostatectomy No. of Patients Potency Rate
Walsh et al15,16 Open 64 Bilateral 73%
Catalona et al17 Open 798 Bilateral 68%
60 Unilateral 47%
Gralnek et al18 Open 46 Unilateral 39%
Rabbani et al19 Open 181 Bilateral 47%
26107* Unilateral 25%
Quinlan et al22 Open 291 Bilateral 82%
96109† Unilateral 58%
Geary et al21 Open 69 Bilateral 32%
203 Unilateral 15%
Fowler et al20 Open Unknown 11%
Turk et al23 Laparoscopic 44 Unilateral/Bilateral 59%
Rassweiler et al24 Laparoscopic 10 Unilateral 40%
Bollens et al25 Laparoscopic 10 Bilateral 60%
Guillonneau et al26 Laparoscopic 20 Bilateral 45%
Roumeguere et al27 Laparoscopic 26 Bilateral 65%
Touijer et al28 Laparoscopic 47‡ Bilateral 66%
Katz et al29 Laparoscopic 143 Unilateral/Bilateral 58%
Menon et al1 Robotic 1100 Unilateral/Bilateral 64%
Ahlering et al32,33 Robotic 51 Unilateral/Bilateral 47%
Chien et al34 Robotic 56 Unilateral/Bilateral 69%
Menon et al31 Robotic 23 Bilateral (conventional) 74%
35 Bilateral (fascia sparing) 97%
Kaul et al30 Robotic 154 Bilateral (fascia sparing) 71%
*Denotes unilateral resection and unilateral/bilateral damage, respectively.
†Denotes inclusion of unilateral preservation with the contralateral nerve being partially excised or widely excised.
‡Denotes a subset of the entire group analyzed.
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sexual intercourse at 6-month follow-up.1,8,14 Of patients
over 60 years of age, 75% had sexual activity and 38% had
sexual intercourse. Using SHIM, Ahlering et al5 reported a
lower 43% potency rate after cautery-free robotic-assisted
prostatectomy when including patients up to the age of
65. Recent reports by Menon et al30,31 describe the out-
comes after robotic-assisted prostatectomy using both
conventional and prostatic fascia-sparing techniques. At
12-month follow-up, 74% of patients having undergone
conventional nerve-sparing robotic-assisted prostatec-
tomy, and 97% of those having undergone the fascia-
sparing procedure achieved erections sufficient for inter-
course. In patients who did not use medications, however,
SHIM scores demonstrated that the percentage achieving
normal erections in the conventional and fascia-sparing
groups was only 17% and 51%, respectively.30–33
Our data are based on the 55 eligible patients able to fulfill
the abovementioned criteria and undergo objective ques-
tioning using the IIEF-5 validated questionnaire. Cur-
rently, the IIEF questionnaire published by Rosen et al10 in
1997 is a worldwide accepted and validated tool in assess-
ing all aspects of sexual function and dysfunction. Of the
55 patients we evaluated, 22 (40%) were impotent, 3
(5.5%) had moderate ED, 12 (21.8%) had mild ED, and 18
(32.7%) were fully potent. Of patients who had bilateral
nerve sparing, 28/45 (62.2%) had mild or no ED within 6
to 12 months postsurgery, and all expressed satisfaction
with their current sexual function or rate of improvement
after robotic prostatectomy. The overall rate of sexual
function at 1 year of 62.2% is comparable to the results in
open and early laparoscopic and robotic surgery. As can
be expected, the majority of these patients had undergone
bilateral nerve-sparing techniques. All of our patients re-
ceive a prescription for oral pharmacologic assistance and
take the medication routinely after surgery and discon-
tinue it when they feel they can do without it. When the
patients are stratified to younger or older than 60, men
under 60 years of age had a statistically significant increase
in the rate of erection sufficient for sexual intercourse;
however, those who were older did not (Mean IIEF-5
scores of 17 versus 10; P0.05). At 6-month follow-up,
20/30 patients (67%) who were 60 reported mild ED or
were fully potent, compared with 10/25 (40%) in those
patients 60. This reinforces the multiple interactions
relating to potency, age being one of them. Our finding is
consistent with findings in the current literature. Table 3
reviews the varying literature on potency rates and
method of prostatectomy. One limitation of our study is
that preoperative potency scores were not attained, which
alters the interpretation of our postoperative results, as a
patient who was impotent preoperatively will not become
potent after surgery thereby lowering our results. This
would render our potency rate to be artificially low due to
inclusion of impotent patients or patients with poor base-
line erectile status. Despite this, our results are encourag-
ing, which also adds a functional outcome to the benefit
of robotic-assisted radical prostatectomy.
The time to recovery of sexual function has also been a
matter of debate. Follow-up times after surgery have been
variable with many studies showing that recovery of erec-
tion is a function of time and may occur more than 1 year
after surgery. Walsh et al15,16 reported an improvement in
potency of 72% to 86% between 12 and 18 months post-
operatively. In the series by Rabbani et al,19 75% of the
men who were potent regained potency after 11.8
months.
CONCLUSION
Robotic-assisted nerve-sparing surgery is currently an es-
tablished and reproducible technique. The benefits of the
robot allow for better visualization and subsequent metic-
ulous dissection and preservation of the neurovascular
bundles. Our preliminary results provide comparable ob-
jective outcomes to open surgery with regards to erectile
function. Assessment of the ultimate maximal erectile
function will require continued analysis, as this is likely to
further improve beyond 6 to 12 months.
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